Speedy review for Jazz’ high-risk AML chemo

6th November 2017 Uncategorised 0

Dublin, Ireland-based Jazz Pharmaceuticals’ Vyxeos is being given a speedy review in Europe as a treatment for certain types of high-risk acute myeloid leukemia (AML).

More: Speedy review for Jazz’ high-risk AML chemo
Source: News